topotecan hydrochloride (Accord Healthcare, Inc.)
Welcome to the PulseAid listing for the topotecan hydrochloride drug offered from Accord Healthcare, Inc.. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Accord Healthcare, Inc. |
| NON-PROPRIETARY NAME: | topotecan hydrochloride |
| SUBSTANCE NAME: | TOPOTECAN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-07-23 |
| END MARKETING DATE: | 0000-00-00 |
topotecan hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | topotecan hydrochloride from Accord Healthcare, Inc. |
| LABELER NAME: | Accord Healthcare, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4(mg/4mL) |
| START MARKETING DATE: | 2013-07-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 16729-151_256208d7-142f-6105-e054-00144ff88e88 |
| PRODUCT NDC: | 16729-151 |
| APPLICATION NUMBER: | ANDA202351 |
Other TOPOTECAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
